Gonorrhoea Vaccine Now Available in UK Clinics
Today marks the launch of gonorrhoea vaccinations in sexual health clinics across the UK, aimed at addressing a worrying surge in infections.
The initial rollout will prioritize individuals considered at high risk, particularly gay and bisexual men with multiple sexual partners or a history of sexually transmitted infections.
NHS England describes this rollout as a notable global milestone, projecting it could avert up to 100,000 cases and potentially save the health service around £8 million over the next ten years.
The Terrence Higgins Trust, a significant advocate for the vaccine’s introduction in the UK, has termed it “a huge win” for sexual health.
Understanding Gonorrhoea
Gonorrhoea is a bacterial infection often spread through unprotected sexual contact. Symptoms can vary widely, including pain, unusual discharge, genital inflammation, and, in more severe cases, infertility. However, some individuals may not show any symptoms at all.
The NHS emphasizes that proper condom use and acceptance of the vaccine, when available, can effectively prevent infections.
Concerns are growing among medical professionals regarding the escalating number of infections. They hope that the new vaccine, which has shown to be 30-40% effective, will also help combat the increasing incidence of antibiotic-resistant gonorrhoea cases.
Interestingly, the vaccine, known as the 4CMenB vaccine, was originally developed to protect against meningitis B in infants. Its effectiveness against gonorrhoea stems from the close relationship between the bacteria responsible for both illnesses.
A staggering 85,000 gonorrhoea cases were reported in 2023, marking the highest numbers since records began nearly a century ago.
Personal Experiences with Gonorrhoea
Joey Knock, who experienced the infection, referred to it as exhausting, leading to symptoms that included diarrhea and significant fatigue. He had to take time off work to recuperate. Reflecting on his experience, Joey mentioned discussing his symptoms with friends, believing he had a notably harsher reaction.
In anticipation of attending a festival abroad, the 35-year-old opted to privately pay for a series of gonorrhoea vaccinations in early 2024, costing him £220. He expressed relief, saying it gives him more control over his sexual health.
Joey combines the protection from the vaccine with other safer sex practices, including taking PrEP to prevent HIV and using DoxyPep after sex to ward off bacterial STIs, a treatment not widely accessible through the NHS. While he sometimes uses condoms, he sees the vaccine as an additional safeguard in situations where he or his partner may prefer not to use them.
After being re-infected with gonorrhoea post-vaccination, Joey noted the symptoms were much milder, allowing him to continue with his daily activities without significant disruption. Regular testing and understanding his body have also been crucial for him.
Community Fear and Anticipation
Matthew, a 63-year-old from East Scotland, recalls being diagnosed with gonorrhoea a decade ago, which led to a painful reaction known as reactive arthritis. This painful experience has left him with lasting joint damage and heightened anxiety about future infections. He compared his current anxiety to feelings from the 1980s concerning HIV, constantly vigilant for symptoms.
He hopes to be among the first to receive the vaccine, emphasizing the importance of protecting both himself and his partners, while also lightening the load on sexual health services that face increasing appointment demands.
Richard Angell, head of the Terrence Higgins Trust, stated that the vaccine represents a valuable addition to sexual health strategies. NHS’s Dr. Amanda Doyle also stressed the need for eligible individuals to take advantage of the vaccine to keep everyone safe.
For those who think they might qualify for the vaccine, reaching out to local sexual health clinics is recommended for further information.
